tyrosine has been researched along with Agnogenic Myeloid Metaplasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaligné, R; Constantinescu, SN; Giraudier, S; Goss, V; Lee, KA; Pecquet, C; Poirel, HA; Polakiewicz, RD; Rush, J; Scheiff, JM; Staerk, J; Vainchenker, W; Van Hees, J; Zhang, X | 1 |
| Martyré, MC; Micouin, A; Steunou, V; Wietzerbin, J | 1 |
| Hankins, WD; Moliterno, AR; Siebel, KE; Spivak, JL; Sun, AY | 1 |
3 other study(ies) available for tyrosine and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor.
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Cell Line; Cell Proliferation; Humans; Immunoblotting; Janus Kinase 2; Mice; Mutation; Myeloproliferative Disorders; Phosphoproteins; Phosphorylation; Precursor Cells, B-Lymphoid; Primary Myelofibrosis; Receptors, Thrombopoietin; Transfection; Tyrosine | 2010 |
Lack of interferon-alpha-induced tyrosine phosphorylation of Vav proto-oncogene in patients with myelofibrosis with myeloid metaplasia.
Topics: Adult; Aged; Female; Humans; Interferon-alpha; Male; Middle Aged; Oncogene Proteins; Phosphorylation; Primary Myelofibrosis; Proto-Oncogene Mas; Proto-Oncogene Proteins c-vav; Tyrosine | 2000 |
A novel thrombopoietin signaling defect in polycythemia vera platelets.
Topics: Blood Platelets; Humans; Janus Kinase 2; Neoplasm Proteins; Phosphorylation; Platelet Aggregation; Polycythemia Vera; Primary Myelofibrosis; Protein-Tyrosine Kinases; Proteins; Proto-Oncogene Proteins; Radioligand Assay; Receptors, Cytokine; Receptors, Thrombopoietin; Signal Transduction; Thrombopoietin; Tyrosine | 1998 |